
Humans may have hibernation ‘superpowers' in untapped genes, scientists say
Hibernating animals such as squirrels and bears exhibit incredible resilience, going long periods without food and water and withstanding near-freezing temperatures by slowing down metabolism. They avoid muscle and nerve decay and stay healthy despite massive weight fluctuations.
When these animals emerge from hibernation, they appear to recover from dangerous symptoms similar to those seen in people suffering from diabetes, Alzheimer's and stroke. 'If we could regulate our genes a bit more like hibernators, maybe we could overcome type 2 diabetes the same way a hibernator returns from hibernation back to a normal metabolic state,' Elliott Ferris, an author of one of the studies, says.
The research focuses on a gene cluster called the 'fat mass and obesity locus', which plays an important role in hibernators.
DNA regions near the FTO locus regulate the activities of neighbouring genes, tuning them up or down. They enable hibernators to put on weight before cosying up for winter and allow them to slowly use their fat reserves throughout hibernation, researchers say.
'What's striking about this region is that it is the strongest genetic risk factor for human obesity,' says Chris Gregg, a senior author of one of the studies from the University of Utah Health.
When researchers mutated the hibernator-specific gene regions in mice, they noticed changes in their metabolism and weight.
Some mutations sped up weight gain while others slowed it down under specific dietary conditions. The mutations also affected the ability of mice to recover body temperature after a hibernation-like state.
'When you knock out one of these elements – this one tiny, seemingly insignificant DNA region – the activity of hundreds of genes changes,' Susan Steinwand, another author of the studies, says.
Previous studies show that hibernating animals can reverse neurodegeneration, avoid muscle decay, remain healthy despite massive weight fluctuations, and show improved ageing and longevity.
The latest studies suggest we possess the necessary genetic code for hibernator-like superpowers, if we can bypass some of our metabolic switches.
'This work provides a genetic framework for harnessing hibernator adaptations to understand human metabolic control,' researchers say.
'Humans already have the genetic framework,' Dr Steinwand says. 'We just need to identify the control switches for these hibernator traits.'
Further studies on these genes and their surrounding DNA regions can help confer similar resilience to humans, scientists say.
'There's potentially an opportunity – by understanding these hibernation-linked mechanisms in the genome – to find strategies to intervene and help with age-related diseases,' Dr Gregg says.
'If that's hidden in the genome that we've already got, we could learn from hibernators to improve our own health.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
2 hours ago
- Reuters
Vertex's trial failure, scrapped study cloud pain drug push; shares slump
Aug 4 (Reuters) - Vertex Pharmaceuticals will stop developing its experimental non-opioid painkiller as a solo treatment after a mid-stage trial failure and will not start a study for expanded use of its approved pain drug, sending its shares down 14.4% after the bell. The company (VRTX.O), opens new tab has been diversifying into gene therapies and non-opioid painkillers as it looks to reduce its reliance on cystic fibrosis drugs, a market it dominates. Unlike opioids, which trigger the brain's reward centers, making them an addiction risk, Vertex's drugs block pain signals at the origin, providing a lucrative opportunity for the company. The next-generation non-opioid painkiller, called VX-993, reduced pain by 74.5 points over 48 hours, compared with 50.2 points in the placebo group, but the difference was not statistically significant, Vertex said. The company tested acute pain reduction in patients who had bunionectomy, a surgery to correct deformed bones of the big toe and foot. The drug was found to be generally safe, with most side effects being mild to moderate and no serious problems linked to the painkiller, the company said. Wall Street analysts and investors have been keenly watching the results of the trial, as Vertex seeks to expand beyond Journavx, its non-opioid approved by the U.S. Food and Drug Administration in January for acute pain. Separately, Vertex also said it would not start a study for Journavx to treat a type of nerve pain in the lower back and legs following discussion with the FDA. Leerink Partners analyst David Risinger said Vertex's pain portfolio updates were "disappointing," despite reporting second-quarter results that were above expectations. Vertex plans to prioritize testing of, and later seeking approval for, Journavx to treat a type of nerve pain in diabetic patients. It will also seek to secure approval for other types of nerve pain, the company said in its earnings press release.


The Independent
4 hours ago
- The Independent
Health warning issued as source of serious bacteria outbreak revealed
Public health officials have issued a warning regarding an outbreak of Campylobacter and E. coli linked to raw milk from an unnamed farm in Florida. The outbreak has affected 21 individuals, including six children under 10, resulting in seven hospitalisations and two severe complications. The Florida Department of Health expressed concerns about sanitation practices at the implicated farm, noting that raw milk is only legally sold for non-human consumption in the state. Federal health agencies, including the CDC and FDA, strongly advise against consuming raw milk due to significant health risks from various pathogens, emphasising that pasteurisation eliminates these dangers. Despite scientific consensus on the risks, raw milk has gained popularity among some groups, with Health and Human Services Secretary Robert F. Kennedy Jr. being a consumer, though his administration has not delivered the regulatory changes raw milk advocates hoped for.


The Independent
4 hours ago
- The Independent
NASA's Curiosity rover can now multitask
NASA 's Curiosity rover, which landed on Mars 13 years ago, has been equipped with significant new capabilities. These upgrades allow the rover to multitask, performing scientific activities while simultaneously conserving energy from its nuclear battery. Curiosity can now communicate with an orbiter, drive, move its robotic arm, and capture images concurrently. The rover can also autonomously decide to power down early if its daily tasks are completed, reducing the need for extensive recharging. These enhancements aim to maximize the lifespan of its power source, as Curiosity continues to explore Martian geological formations believed to be formed by ancient water.